Molecular Basis of Coronavirus Virulence and Vaccine Development
- 30 August 2016
- book chapter
- review article
- Published by Elsevier BV
- Vol. 96, 245-286
- https://doi.org/10.1016/bs.aivir.2016.08.003
Abstract
No abstract availableKeywords
This publication has 188 references indexed in Scilit:
- A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal diseaseNature Medicine, 2012
- Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver PathologyCell Host & Microbe, 2012
- Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoVVaccine, 2011
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5Nature Immunology, 2011
- Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory diseaseVirology, 2010
- A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoVirology, 2009
- Vaccines to prevent severe acute respiratory syndrome coronavirus-induced diseaseVirus Research, 2008
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzymeProceedings of the National Academy of Sciences of the United States of America, 2006
- Identification of a new human coronavirusNature Medicine, 2004